India may approve anti-COVID-19 drug molnupiravir soon: Report
Shortpedia
Content Team
Image Credit: Dawn
India is reportedly likely to approve Merck's anti-COVID-19 drug molnupiravir soon. Emergency Use Authorization (EUA) for the drug may come within days, Dr. Ram Vishwakarma told NDTV. Dr. Vishwakarma is the chairperson of the COVID-19 Strategy Group, Council Of Scientific And Industrial Research (CSIR). Pfizer's anti-COVID-19 pill Paxlovid may take longer, he said.
